7th Annual Biomarkers Congress
February 21, 2012 at 8:00 AM - February 22, 2012 at 5:00 PM
Hilton Manchester Deansgate Hotel, Manchester
The pharmaceutical industry is facing high clinical development costs and declining drug discovery success rates. To stay competitive companies are re-evaluating their drug development process to reduce attrition rates. Biomarkers promise to transform drug discovery, clinical development and diagnostics in the R&D process as effective use of biomarkers at each stage of R&D can improve decision-making, increase clinical trial success rates and productivity. The 7th Annual Biomarkers Congress 2012 presented by Oxford Global Conferences provides a first class educational and networking opportunity for over 250 attendees to gain knowledge and insights into the Biomarkers marketplace.
Event Owner: Ross McIvor (Marketing Manager at Oxford Global Conferences)

Updates

Marina Mollenhauer-Thein (Biomarker Expert at Nycomed: a Takeda Company) attended.
David Browne (at York Bioanalytical Solutions) will be attending.
Esha Gangolli (Associate Director, Translational Medicine at Millennium Pharmaceuticals) will be attending.
Coralie Vacher (Senior Sales & Business Development Consultant - Nordic Countries & London Key Account Manager) will be attending.
Bernard McKeown (Client Manager - JMP at SAS) will be attending.
Fabio Magrini (Senior Medical Director at MedImmune) will be attending.
Adrian Skipper (Managing Director, Affinity Group Limited, HR Recruitment Consultancy) will be attending.
Claire Jenkins (Commercial Director at Arrayjet Ltd) will be attending.
NR Nirmala (Head, Biomarker Analysis and Informatics Unit) will be attending.
John Feder (Associate Director of Genome Biology at Bristol-Myers Squibb) will be attending.
Show More...
Become a LinkedIn member. It's free!
Network with others attending this event
Attendees by company
Oxford Global
2
York Bioanalytical Solutions
1
Millennium the Takeda Oncology Company
1
Beckman Coulter Genomics (formerly Cogenics)
1
SAS
1